December 31, 2021

CBD Global Sciences Announces Retirement of Over $9 Million in Outstanding Debt

CBD Global Sciences, Inc.  is pleased to announce the completion of its previously announced (August 12, 2021) debt restructuring involving the retirement of over CDN$9 million in outstanding debt through the issuance of 8,908,876 Common Shares at an issue price of $0.1575 per share and 318,688 Series A preferred shares […]
December 16, 2021

CBD Global Sciences Reports Improving Q3 2021 Financial Results

CBD Global Sciences, Inc. is pleased to share their Q3 2021 results with highlighted details on the Company’s progress. The Company filed its Q3 financials and MD&A on November 29, 2021 to the regulators and the Canadian Securities Exchange. The financials submitted reflect some of the positive results of the […]
December 7, 2021

Legacy Distribution Group, a Subsidiary of CBD Global Sciences, to Begin Distribution for Lil’ Baby’s Oowee Lemonade by RAP SNACKS®

CBD Global Sciences, Inc. is pleased to share that it is adding new brands to its growing distribution channel. Legacy Distribution Group is one of the country’s first CBD-focused Direct Store Delivery (DSD) distributors. Dedicated to providing “Best in Class” products to its retailers, we are focused on introducing both CBD and […]
August 25, 2020

Global Sciences Reports 2019 Year End Results

CBD Global Sciences, Inc.  today announced the release of financial and operational results for the fourth quarter ended December 31,2019. These filings are available for review on the Company’s SEDAR profile at www.sedar.com. All amounts are expressed in U.S. dollars. Financial Highlights For the twelve months ended December 31, 2019 […]
December 11, 2019

Global Sciences Signs Agreement to Expand Aethics Product Distribution

CBD Global Sciences, Inc. today expanded its Aethics brand through a distribution agreement with a leading specialty beverages and healthy lifestyle products company. This agreement expands access to traditional retail, e-commerce, and other supply channels nationally. This opportunity will increase distribution of Aethics products with some of the world’s largest […]
December 5, 2019

Global Sciences Reports Q3 2019 Results with Revenue of $1.79 million up over 1,000% from Q3 2018 Revenue of $144,000

CBD Global Sciences, Inc.  today announced the release of financial and operational results for the third quarter ended September 30, 2019. These filings are available for review on the Company’s SEDAR profile at www.sedar.com. All amounts are expressed in U.S. dollars. Financial Highlights For the nine months ended September 30, […]